Condition: Crimean-Congo Haemorrhagic Fever · Sponsor: Liverpool School of Tropical Medicine
The goal of this medical device diagnostic evaluation study is to determine if this novel lateral flow device can detect Crimean-Congo Hemorrhagic Fever (CCHF) at the point of care in secondary health care clinics in Turkey. The main outcome is to determine the sensitivity and specificity of the tests for CCHF in samples of whole blood, serum and capillary blood compared to a gold-standard of PCR for participants that present at 4 endemic sites secondary health care clinics in Turkey in 492 adults who are suspected to have been infected with CCHF. The study aims to hopes to achieve at least the minimum required sensitivity of 90 % and specificity of 80 % as required by the WHO.
This description comes directly from the study's public registry record.
Ravi Lad · 151 705 3364 · ravi.lad@lstmed.ac.uk
Ana Cubas Atienzar, PhD · 151 705 3364 · Ana.CubasAtienzar@lstmed.ac.uk
Always discuss trial participation with your own doctor first.
| Atatürk University | Erzurum, Turkey (Türkiye) | Recruiting |
| Erzurum City Hospital | Erzurum, Turkey (Türkiye) | Recruiting |
| Kastamonu Üniversitesi | Kastamonu, Turkey (Türkiye) | Recruiting |
| Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Samsun | Samsun, Turkey (Türkiye) | Recruiting |
| Sivas Cumhuriyet University | Sivas, Turkey (Türkiye) | Recruiting |
| Tokat Gaziosmanpaşa University | Tokat Province, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06624787